U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by US Bancorp DE

US Bancorp DE lessened its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,142 shares of the company’s stock after selling 600 shares during the period. US Bancorp DE owned about 0.06% of U.S. Physical Therapy worth $774,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in USPH. Semanteon Capital Management LP bought a new position in shares of U.S. Physical Therapy in the 3rd quarter worth about $776,000. International Assets Investment Management LLC lifted its holdings in U.S. Physical Therapy by 8,414.8% in the third quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock worth $195,000 after acquiring an additional 2,272 shares during the last quarter. Precision Wealth Strategies LLC lifted its holdings in U.S. Physical Therapy by 5.1% in the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock worth $239,000 after acquiring an additional 137 shares during the last quarter. Penn Davis Mcfarland Inc. acquired a new position in U.S. Physical Therapy in the third quarter valued at approximately $2,552,000. Finally, NBC Securities Inc. grew its holdings in shares of U.S. Physical Therapy by 8.0% during the third quarter. NBC Securities Inc. now owns 8,523 shares of the company’s stock valued at $721,000 after purchasing an additional 633 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $95.08 on Friday. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63. The company has a market cap of $1.43 billion, a PE ratio of 101.15, a P/E/G ratio of 4.67 and a beta of 1.38. The stock has a 50 day simple moving average of $83.62 and a 200-day simple moving average of $91.44. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company’s revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.76 EPS. On average, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.54 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.

Analyst Ratings Changes

USPH has been the topic of several recent research reports. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America reaffirmed a “neutral” rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, Barrington Research reissued an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday.

Insider Activity at U.S. Physical Therapy

In other news, Director Kathleen A. Gilmartin acquired 2,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the purchase, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.